Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 RET mutations in neuroendocrine tumors: including small-cell lung cancer.

Literature DB >> 25122419

RET mutations in neuroendocrine tumors: including small-cell lung cancer.

Charles M Rudin¹, Alexander Drilon, J T Poirier.

Abstract

Entities: Chemical Disease Gene Mutation Species

Mesh：

Substances：

Year: 2014 PMID： 25122419 PMCID： PMC4137454 DOI： 10.1097/JTO.0000000000000301

Source DB: PubMed Journal: J Thorac Oncol ISSN： 1556-0864 Impact factor: 15.609

× No keyword cloud information.

15 in total

1. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.

Authors: Sina Jasim; Anita K Ying; Steven G Waguespack; Thereasa A Rich; Elizabeth G Grubbs; Camilo Jimenez; Mimi I Hu; Gilbert Cote; Mouhammed Amir Habra
Journal: Thyroid Date: 2010-12-27 Impact factor: 6.568

2. Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma.

Authors: L M Mulligan; T Timmer; S M Ivanchuk; B G Campling; L C Young; P H Rabbitts; V Sundaresan; R M Hofstra; C Eng
Journal: Genes Chromosomes Cancer Date: 1998-04 Impact factor: 5.006

Review 3. An update on molecular biology of thyroid cancers.

Authors: Ozgur Omur; Yusuf Baran
Journal: Crit Rev Oncol Hematol Date: 2013-12-18 Impact factor: 6.312

4. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

Authors: Young Seok Ju; Won-Chul Lee; Jong-Yeon Shin; Seungbok Lee; Thomas Bleazard; Jae-Kyung Won; Young Tae Kim; Jong-Il Kim; Jin-Hyoung Kang; Jeong-Sun Seo
Journal: Genome Res Date: 2011-12-22 Impact factor: 9.043

5. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

Authors: C Eng; D Clayton; I Schuffenecker; G Lenoir; G Cote; R F Gagel; H K van Amstel; C J Lips; I Nishisho; S I Takai; D J Marsh; B G Robinson; K Frank-Raue; F Raue; F Xue; W W Noll; C Romei; F Pacini; M Fink; B Niederle; J Zedenius; M Nordenskjöld; P Komminoth; G N Hendy; L M Mulligan
Journal: JAMA Date: 1996-11-20 Impact factor: 56.272

6. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Authors: Doron Lipson; Marzia Capelletti; Roman Yelensky; Geoff Otto; Alex Parker; Mirna Jarosz; John A Curran; Sohail Balasubramanian; Troy Bloom; Kristina W Brennan; Amy Donahue; Sean R Downing; Garrett M Frampton; Lazaro Garcia; Frank Juhn; Kathy C Mitchell; Emily White; Jared White; Zac Zwirko; Tamar Peretz; Hovav Nechushtan; Lior Soussan-Gutman; Jhingook Kim; Hidefumi Sasaki; Hyeong Ryul Kim; Seung-il Park; Dalia Ercan; Christine E Sheehan; Jeffrey S Ross; Maureen T Cronin; Pasi A Jänne; Philip J Stephens
Journal: Nat Med Date: 2012-02-12 Impact factor: 53.440

7. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

Authors: A Fusco; M Grieco; M Santoro; M T Berlingieri; S Pilotti; M A Pierotti; G Della Porta; G Vecchio
Journal: Nature Date: 1987 Jul 9-15 Impact factor: 49.962

8. RET, ROS1 and ALK fusions in lung cancer.

Authors: Kengo Takeuchi; Manabu Soda; Yuki Togashi; Ritsuro Suzuki; Seiji Sakata; Satoko Hatano; Reimi Asaka; Wakako Hamanaka; Hironori Ninomiya; Hirofumi Uehara; Young Lim Choi; Yukitoshi Satoh; Sakae Okumura; Ken Nakagawa; Hiroyuki Mano; Yuichi Ishikawa
Journal: Nat Med Date: 2012-02-12 Impact factor: 53.440

RET mutations in neuroendocrine tumors: including small-cell lung cancer.

1. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.

2. Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma.

Review 3. An update on molecular biology of thyroid cancers.

4. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

5. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

6. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

7. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases.

8. RET, ROS1 and ALK fusions in lung cancer.

9. RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons.

10. A novel somatic point mutation of the RET Proto-oncogene in tumor tissues of small cell lung cancer patients.

Review 1. Cellular and molecular biology of small cell lung cancer: an overview.

Review 2. Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.

Review 3. Revisiting the Role of Neurotrophic Factors in Inflammation.

Review 4. Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression.

Review 5. Resistance to KRAS^G12C Inhibitors in Non-Small Cell Lung Cancer.

Review 3. An update on molecular biology of thyroid cancers.

Review 1. Cellular and molecular biology of small cell lung cancer: an overview.

Review 2. Neurotrophic Factors and Their Potential Applications in Tissue Regeneration.

Review 3. Revisiting the Role of Neurotrophic Factors in Inflammation.

Review 4. Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression.

Review 5. Resistance to KRASG12C Inhibitors in Non-Small Cell Lung Cancer.

Review 5. Resistance to KRAS^G12C Inhibitors in Non-Small Cell Lung Cancer.